Drug intelligence / Profile preview

red yeast rice + atorvastatin

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Red yeast rice + atorvastatin represents a combination of a dietary supplement (red yeast rice) with a prescription statin medication (atorvastatin). This combination is generally not recommended by healthcare professionals due to potential safety concerns. Red yeast rice contains monacolin K, which is chemically identical to the prescription drug lovastatin. When combined with atorvastatin (Lipitor), this creates a situation where a patient would effectively be taking two statin medications simultaneously, which could increase the risk of side effects without providing proportional benefits[2][5]. While some research has investigated adding red yeast rice to statin therapy, the safety profile of this specific combination remains concerning. A triple-blind randomized clinical trial found that adding red yeast rice to statin medications significantly decreased total cholesterol, but showed no significant effect on other lipid profile components[1]. ## Safety Concerns The combination carries several potential risks: 1. **Increased risk of statin side effects**: Both components can cause similar adverse effects including muscle pain, liver damage, and kidney problems[2][3][5]. 2. **Unpredictable dosing**: Red yeast rice supplements vary widely in their monacolin K content, making it difficult to control the total statin dose when combined with atorvastatin[3]. 3. **Drug interactions**: The combination may interact with the same medications that statins typically interact with, including blood thinners, certain antibiotics, antifungals, and other medications[4][5]. According to the search results, this combination is classified as a "Moderate Drug Interaction" where it's usually advised to avoid the combination except under special circumstances[7].

Other names
red yeast rice and low-dose atorvastatinRYR + atorvastatin
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on red yeast rice + atorvastatin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on red yeast rice + atorvastatin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call